Taylor, Cottrill, Erickson & Associates, Inc. Abiomed Inc Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$359 Million
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$300.63 - $371.35 $1.13 Million - $1.39 Million	-3,745 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$310.19 - $376.2 $74,445 - $90,288	240 Added 6.85%	3,745 $1.22 Million
Q2 2021 Jul 20, 2021	SELL	$262.71 - $351.17 $65,677 - $87,792	-250 Reduced 6.66%	3,505 $1.09 Million
Q2 2019 Jul 26, 2019	SELL	$250.96 - $284.94 $92,855 - $105,427	-370 Reduced 8.97%	3,755 $978,000
Q3 2017 Oct 19, 2017	BUY	$145.39 - $168.6 $599,733 - $695,475	4,125	4,125 $695,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account